Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 15.21
+0.84 (5.85%)
Jun 29, 2026, 3:00 PM CST
SHA:603858 Market Cap
SHA:603858 has a market cap or net worth of 16.04 billion as of June 29, 2026. Its market cap has decreased by -9.22% in one year.
Market Cap
16.04B
Enterprise Value
18.12B
Revenue
11.67B
Ranking
n/a
PE Ratio
42.88
Stock Price
15.21
Market Cap Chart
Since November 18, 2016, SHA:603858's market cap has decreased from 54.86B to 16.04B, a decrease of -70.76%. That is a compound annual growth rate of -12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 16.04B | -2.75% |
| Dec 31, 2025 | 16.49B | -2.05% |
| Dec 31, 2024 | 16.84B | -10.50% |
| Dec 29, 2023 | 18.81B | -19.04% |
| Dec 30, 2022 | 23.24B | -0.38% |
| Dec 31, 2021 | 23.33B | -8.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 17.97B |
| Hybio Pharmaceutical | 17.46B |
| Dizal (Jiangsu) Pharmaceutical | 16.97B |
| Kangmei Pharmaceutical | 16.73B |
| Joincare Pharmaceutical Group Industry | 16.58B |
| China Resources Double-Crane Pharmaceutical | 16.11B |
| ApicHope Pharmaceutical Group | 14.58B |
| Tonghua Dongbao Pharmaceutical | 14.53B |